SALIX PHARMACEUTICALS LTD Amortization of Intangible Assets
SALIX PHARMACEUTICALS LTD reported Amortization of Intangible Assets of $216.10 million for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-02.
Discontinued › Expense Statement › Operating Expenses
us-gaap:AmortizationOfIntangibleAssets · last filed 2015-03-02
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for the quarter ending 2014-12-31 was $54.25M, a 383.28% increase year-over-year.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for the quarter ending 2014-09-30 was $55.04M, a 391.91% increase year-over-year.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for the quarter ending 2014-06-30 was $53.91M, a 382.98% increase year-over-year.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for the quarter ending 2014-03-31 was $53.90M, a 382.65% increase year-over-year.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for fiscal 2014 was $216.10M, a 382.97% increase from fiscal 2013.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for fiscal 2013 was $44.74M, a 1.34% decline from fiscal 2012.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for fiscal 2012 was $45.35M, a 315.76% increase from fiscal 2011.
- SALIX PHARMACEUTICALS LTD amortization of intangible assets for fiscal 2011 was $10.91M, a 5.19% increase from fiscal 2010.
| Period end | Amortization of Intangible Assets 3 month | Amortization of Intangible Assets 3 month as first filed | Amortization of Intangible Assets 6 month | Amortization of Intangible Assets 6 month as first filed | Amortization of Intangible Assets 9 month | Amortization of Intangible Assets 9 month as first filed | Amortization of Intangible Assets 12 month |
|---|---|---|---|---|---|---|---|
| 2014-12-31 | $54.25M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $108.30M derived: sum of 2 quarters · filed 2015-03-02 | $162.21M derived: sum of 3 quarters · filed 2015-03-02 | $216.10M 10-K · filed 2015-03-02 | |||
| 2014-09-30 | $55.04M 10-Q · filed 2014-11-07 | $107.95M derived: sum of 2 quarters · filed 2015-03-02 | $161.85M 10-Q/A · filed 2015-03-02 | $164.84M 10-Q · filed 2014-11-07 | $173.07M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2014-06-30 | $53.91M 10-Q/A · filed 2015-03-02 | $54.91M 10-Q · filed 2014-08-08 | $107.81M 10-Q/A · filed 2015-03-02 | $109.80M 10-Q · filed 2014-08-08 | $119.03M derived: sum of 3 quarters · filed 2015-03-02 | $130.22M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2014-03-31 | $53.90M 10-Q/A · filed 2015-03-02 | $54.90M 10-Q · filed 2014-05-09 | $65.12M derived: sum of 2 quarters · filed 2015-03-02 | $76.31M derived: sum of 3 quarters · filed 2015-03-02 | $87.47M derived: sum of 4 quarters · filed 2015-03-02 | ||
| 2013-12-31 | $11.23M derived: 10-K 12 month − 10-Q/A 9 month · filed 2015-03-02 | $22.41M derived: sum of 2 quarters · filed 2015-03-02 | $33.58M derived: sum of 3 quarters · filed 2015-03-02 | $44.74M 10-K · filed 2015-03-02 | |||
| 2013-09-30 | $11.19M 10-Q/A · filed 2015-03-02 | $22.35M derived: sum of 2 quarters · filed 2015-03-02 | $33.52M 10-Q/A · filed 2015-03-02 | $44.84M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | $11.16M 10-Q/A · filed 2015-03-02 | $22.33M 10-Q/A · filed 2015-03-02 | $33.65M derived: sum of 3 quarters · filed 2015-03-02 | $44.99M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | $11.17M 10-Q/A · filed 2015-03-02 | $22.48M derived: sum of 2 quarters · filed 2015-03-02 | $33.83M derived: sum of 3 quarters · filed 2015-03-02 | $45.17M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | $11.32M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $22.66M derived: sum of 2 quarters · filed 2015-03-02 | $34.01M derived: sum of 3 quarters · filed 2015-03-02 | $45.35M 10-K · filed 2015-03-02 | |||
| 2012-09-30 | $11.35M 10-Q · filed 2013-11-08 | $22.69M derived: sum of 2 quarters · filed 2013-11-08 | $34.03M 10-Q · filed 2013-11-08 | $36.92M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-06-30 | $11.34M 10-Q · filed 2013-08-09 | $22.69M 10-Q · filed 2013-08-09 | $25.58M derived: sum of 3 quarters · filed 2015-03-02 | $28.47M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-03-31 | $11.35M 10-Q · filed 2013-05-10 | $14.24M derived: sum of 2 quarters · filed 2015-03-02 | $17.13M derived: sum of 3 quarters · filed 2015-03-02 | $20.02M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2011-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $5.78M derived: sum of 2 quarters · filed 2015-03-02 | $8.67M derived: sum of 3 quarters · filed 2015-03-02 | $10.91M 10-K · filed 2015-03-02 | |||
| 2011-09-30 | $2.89M 10-Q · filed 2012-11-08 | $5.78M derived: sum of 2 quarters · filed 2012-11-08 | $8.02M 10-Q · filed 2012-11-08 | $10.29M derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-06-30 | $2.89M 10-Q · filed 2012-08-09 | $5.13M 10-Q · filed 2012-08-09 | $7.40M derived: sum of 3 quarters · filed 2013-03-01 | $9.88M derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2011-03-31 | $2.24M 10-Q · filed 2012-05-08 | $4.51M derived: sum of 2 quarters · filed 2013-03-01 | $6.99M derived: sum of 3 quarters · filed 2013-03-01 | $9.80M derived: sum of 4 quarters · filed 2013-03-01 | |||
| 2010-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | $4.75M derived: sum of 2 quarters · filed 2013-03-01 | $7.56M derived: sum of 3 quarters · filed 2013-03-01 | $10.37M 10-K · filed 2013-03-01 | |||
| 2010-09-30 | $2.48M 10-Q · filed 2011-11-09 | $5.29M derived: sum of 2 quarters · filed 2011-11-09 | $8.10M 10-Q · filed 2011-11-09 | ||||
| 2010-06-30 | $2.81M 10-Q · filed 2011-08-09 | $5.62M 10-Q · filed 2011-08-09 | |||||
| 2010-03-31 | $2.81M 10-Q · filed 2011-05-10 | ||||||
| 2009-12-31 | $11.48M 10-K · filed 2012-02-28 |